Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
Abildgaard
C F
CF
University of California, Davis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000910:Antibodies, Heterophile / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D006224:Cricetinae; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008647:Mesocricetus / Q000276:immunology*; D051379:Mice / Q000276:immunology*; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000276:immunology* / Q000627:therapeutic use
D000910:Antibodies, Heterophile; D011993:Recombinant Fusion Proteins; D005169:Factor VIII